The largest DNA ancestry service in the world sign in register kit
23andMe provides ancestry-related genetic reports and uninterpreted raw genetic data. We no longer offer our health-related genetic reports. If you are a current customer please go to the health page for more information. Close alert.
23andMe provides ancestry-related genetic reports and uninterpreted raw genetic data. We no longer offer our health-related genetic reports. If you are a current customer please go to the health page for more information. Close alert.

Leadership Team

Anne Wojcicki
Anne Wojcicki CEO and Co-Founder

Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Presently, 23andMe has built one of the world's largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne's leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.

Andy Page
Andy Page President

Andy Page brings corporate leadership, financial acumen and deep operational expertise to 23andMe. Andy has been a member of the 23andMe board of directors since 2012 and joined the company as President in 2013. As President, Andy leads the company’s product and engineering, marketing, finance, business development, laboratory operations and legal/regulatory affairs functions. In addition, he is responsible for developing the company’s business strategy and identifying opportunities for long-term growth and industry leadership. Before joining 23andMe, Andy served as the President of Gilt Groupe, an online luxury shopping destination, where he oversaw the Company’s various businesses and operations including Women’s, Men’s, Kids & Baby, Home, Park & Bond, Gilt City and Gilt Taste. He joined Gilt in April 2010 as the Chief Financial Officer and transitioned to President in 2011. Prior to joining Gilt, Andy was Chief Operating and Financial Officer at PlayPhone, Inc., where he was responsible for managing the company’s multinational operations. Before PlayPhone, Andy was Chief Financial Officer and SVP of Business Strategy of StubHub Inc. There he managed the company’s financial operations, business strategy, financial reporting, and administrative functions. He led the company’s sale to eBay in 2007. Andy has also held senior executive positions at Panasas Inc., ONI Systems Corp., and Robertson Stephens & Company. Andy holds a BA from Princeton University and a MBA from Harvard Business School. He is an advisor to several private e-commerce companies. He also serves on the board of directors of My New Red Shoes, a nonprofit organization that provides back-to-school clothes for homeless and low-income children in the San Francisco Bay Area.

“Brad
Brad Kittredge VP Product

As VP Product, Brad Kittredge is responsible for all elements of the 23andMe user experience, including product vision, design and management. Prior to joining 23andMe, Brad served as director of product management, health at Jawbone. Prior to his tenure at Jawbone, Brad was manager of corporate strategy at McKesson Corp and CEO and founder of ComplexDx, a startup concept focused on solutions to resolve complex medical cases by connecting patients and physicians. Brad holds an MBA from the Walter A. Haas School of Business; a Master's degree in Public Health Management, Health Policy from the University of California, Berkeley; a Master's in International Affairs from the University of California, San Diego and a Bachelor's degree in Psychology from the University of California, Berkeley.

Brian Naughton
Brian T. Naughton, PhD Founding Scientist

Brian joined 23andMe at its founding drawing on his experience in bioinformatics, statistics and genetics to analyze data, develop algorithms and translate scientific research to drive the world's first Personal Genome Service®. Among other projects, Dr. Naughton has worked on the design and development of the company's custom genotyping arrays and other sequencing technologies. In addition, Brian has worked on the development of the company's tools related both to risk estimation and ancestry. Brian received his PhD from the Biomedical Informatics program at Stanford University and is a graduate of Trinity College, Dublin in Ireland.

Jeff Pollard
Jeffrey D. Pollard, MD Director of Medical Affairs

Dr. Pollard joined 23andMe as Director of Medical Affairs in 2012 and is responsible for the company's efforts to advance the integration of personal genomics into the modern healthcare environment through educational initiatives and strategic partnerships with integral members of the healthcare system. He is a double board-certified physician and surgeon with over a decade of clinical experience and has published numerous research articles, contributed to textbooks and trained other surgeons around the nation. Prior to joining 23andMe, Dr. Pollard co-founded and served as Medical Director of Surgical Services for Réviance, a multi-center specialty practice and surgical center. He also served as Medical Expert Network Director for HealthTap, an innovative digital and mobile health platform. Dr. Pollard was also selected as a regional educator by Allergan, Inc. responsible for training healthcare providers in advanced medication delivery techniques to enhance clinical outcomes. Dr. Pollard holds a B.S. in Health Psychology from Duke University and M.D. from Vanderbilt University. He completed both his Internship in General Surgery and Residency in Otolaryngology-Head and Neck Surgery at Stanford University and fellowship training in Facial Plastic and Reconstructive Surgery with Calvin M. Johnson, Jr., M.D. at Tulane University. He is a member of the American Academy of Facial Plastic & Reconstructive Surgery and the American Academy of Otolaryngology-Head and Neck Surgery.

Joanna L. Mountain
Joanna L. Mountain, PhD Senior Director of Research

Joanna joined 23andMe in 2007 as a senior member of the Research Team. She served on the faculties of the Anthropological Sciences and Genetics Departments at Stanford University. Dr. Mountain's professional and research interests include the patterns of genetic etiology across a broad range of human traits, the prehistory underlying human genetic diversity, and the nature of the relationship between genetic diversity and categories of race and ethnicity. Joanna has been awarded multiple grants from the National Science Foundation and the National Institutes of Health and has published over 40 papers in the field of human genetics. She spent two years as a Peace Corps volunteer teaching at a community school near the Kenyan coast and continues to be particularly interested in the genetic diversity of Africa. Dr. Mountain earned a PhD in Genetics and a BS in Mathematical Sciences, both from Stanford, and conducted postdoctoral research on human evolutionary genetics at the University of California, Berkeley.

Jonathan Ward
Jonathan Ward VP International

Jonathan Ward joined 23andMe in 2012 and currently serves as Vice President, International, with responsibility for growing the company's international operations, including consumer offerings and strategic business opportunities. Prior to joining 23andMe, Jonathan served most recently as interim Chief Marketing Officer at eHarmony.com and held a variety of marketing and business development roles during his eight-year tenure there. Jonathan has also held marketing and business development roles at America Online. Prior to AOL, Jonathan was a management consultant with McKinsey & Company, and an associate at Ogilvy, Adams & Rinehart. Jonathan has a bachelor of arts degree in English from Williams College and holds a master's in management from the J.L. Kellogg School of Management at Northwestern University.

Kathy Hibbs
Kathy Hibbs Chief Legal and Regulatory Officer

Kathy Hibbs, Esq. joined 23andMe as Chief Legal and Regulatory Officer in 2014. Kathy brings more than 20 years of legal and management expertise in the clinical laboratory and medical device industries to 23andMe. Prior to joining 23andMe, Kathy served as senior vice president and general counsel, responsible for the legal, regulatory and business development functions at Genomic Health, Inc. Kathy has also held related posts at Monogram Biosciences Inc., and Varian Medical Systems, Inc.. Kathy is active in several industry groups including the American Clinical Laboratory Association (ACLA), the Coalition for 21st Century Medicine and the Personalized Medicine Coalition (PMC). Kathy holds a Juris Doctorate from the University of California, Hastings School of Law, and a Bachelors of Arts in Political Science, from the University of California, Riverside.

Neil Rothstein
Neil Rothstein VP Marketing

As VP Marketing, Neil Rothstein is responsible for the marketing, branding and customer acquisition activities of the company. Prior to joining 23andMe, Neil worked at Netflix for 11 years most recently serving as VP, Online Marketing where he led the company's global online marketing activities across the US, Canada, Latin America, UK, and Ireland. Neil has also had roles with RateItAll, ESPN, and the Atlanta Committee for the Olympic Games. Neil received an MBA from the Gouizueta Business School at Emory University and a BA in Economics from Brandeis University.

Steve Lemon
Steve Lemon VP Engineering

Steve joined 23andMe in 2010 and is responsible for engineering. Prior to 23andMe, Steve was VP of engineering at Loopt and co-founder and VP of technology at Glimpse.com (acquired by TheFind.com). Earlier Steve served as the VP of engineering for Consumer Products and Solutions at Symantec and headed the engineering team at Cendura (acquired by CA), growing development and QA teams in both the U.S. and India. He also served as the SVP and GM of the Internet Portal Division for Healtheon/WebMD (IPO: HLTH), where he operated worldwide engineering and business teams and drove M&A technology integration. He holds three U.S. patents in the area of Object Oriented Operating System Technology. Steve received a BS in Computer Science from The Ohio State University.

“Steve
Steve Schwartz VP Business Development & Strategy

As VP Business Development & Strategy, Steve Schwartz leads 23andme's Business Development team working with partners in life sciences, retail, academic medicine, and healthcare. Steve is a health information technology veteran with more than 25 years clinical laboratory, decision support and electronic health records industry experience. Prior to joining 23andMe Steve was Senior Vice president of Business Development & Strategy at Allscripts, a leading provider of electronic health records. Prior to Allscripts, Steve helped lead a personalized patient education portal startup, Medifor Inc., which was acquired by Allscripts. Preceding Medifor, Steve was a sales and business development executive at Labcorp. Steve holds degrees in Business Administration and Psychology from the University of Washington.